Medium-term targets include 10% earnings growth and 20%+ ROE, with strong progress in asset management and Asia. U.S. stop-loss remains resilient, while dental shifts focus to commercial segments. Asset management integration and a management equity plan aim to drive growth, and capital allocationā¦Read More
